Clinical trialNCT06498479RecruitingPhase 3Interventional

ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer

SponsorHansoh BioMedical R&D CompanyEnrollment460Small Cell Lung Cancer

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China

Beijing Cancer Hospital
Beijing, Beijing Municipality, China
Jian Fang
Not, yet, recruiting
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
Baogang Liu
Not, yet, recruiting
Henan Cancer Hospital
Zhengzhou, Henan, China
Qiming Liu
Not, yet, recruiting
Jilin Cancer Hospital
Changchun, Jilin, China
Ying Cheng
Recruiting
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
Wei Zheng
Not, yet, recruiting
Shandong Cancer Hospital
Jinan, Shandong, China
Haiyong Wang
Not, yet, recruiting
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China
Peng Zhang
Not, yet, recruiting
the First Affiliate Hospital of Guangzhou Medical University
Guangzhou, China
Ming Liu
Not, yet, recruiting
Tongji Hospital
Wuhan, China
Qian Chu
Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 4 Jul 2024
Primary completion: 30 Sept 2026
Completion: 31 May 2027
Last update posted: 16 Oct 2024
Registered enrollment: 460
Registry id: NCT06498479

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.